Atherosclerosis News and Research

RSS

Atherosclerosis is the progressive buildup of plaque - the fatty deposits and other cells - in the inner walls of the arteries. The condition is a consequence of elevated cholesterol and for many it's a silent disease, with no visible signs or symptoms. The disease can begin in early adulthood and continues to progress for the rest of a person's life. Despite the serious nature of atherosclerosis, many people do not understand how it develops and progresses.

Findings open up improved treatment possibilities for children suffering from leukaemia

A research team led by Nanyang Technological University (NTU) scientists have made a key finding which is expected to open up improved treatment possibilities for children suffering from leukaemia.

14 Aug 2014

Researchers make significant step forward in understanding mechanisms that cause leukaemia

Scientists from Queen Mary University of London have discovered mutations in genes that lead to childhood leukaemia of the acute lymphoblastic type - the most common childhood cancer in the world.

13 Aug 2014

Scientists identify long-overlooked function of vascular smooth muscle cells in atherosclerosis

Scientists at the Interfaculty Institute of Biochemistry (IFIB) have collaborated with colleagues from the Department of Pharmacy and the Department of Dermatology of the University of Tübingen to identify a long-overlooked function of vascular smooth muscle cells in atherosclerosis.

12 Aug 2014

Midlife hypertension link to later-life cognitive decline strengthened

Analysis of the Atherosclerosis Risk in Communities study cohort supports an association between elevated blood pressure in midlife and increased cognitive decline in older age.

11 Aug 2014

Scientists discover gene that plays vital role in blood vessel formation

Scientists from the University of Leeds have discovered a gene that plays a vital role in blood vessel formation, research which adds to our knowledge of how early life develops.

11 Aug 2014

CardioNova initiates Phase 1b clinical trial with AtheroNova's AHRO-001

AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces that its partner, CardioNova, has accomplished first dosing of subjects for its Phase 1b clinical trial with AtheroNova's lead compound, AHRO-001.

30 Jul 2014

Diet rich in soy may help feminine hearts, but timing matters

A diet rich in soy may help feminine hearts, but timing matters, finds a new study published online today in Menopause, the journal of The North American Menopause Society.

30 Jul 2014

UTHealth scientists identify inhibitory switch to prevent peripheral vascular disease

Millions of people in the United States have a circulatory problem of the legs called peripheral vascular disease. It can be painful and may even require surgery in serious cases. This disease can lead to severe skeletal muscle wasting and, in turn, limb amputation.

25 Jul 2014

Study examines mechanism of bone-protective properties of California dried plums

Fifty-seven million Americans suffer from low bone density or osteoporosis, a disease which causes bones to become so weak and brittle that even a minor fall or other stresses may cause fractures.

17 Jul 2014

Surgeon explains who needs screening for abdominal aortic aneurysms

Bulges in body's major blood vessel can cause potentially lethal ruptures, blood clots. An abdominal aortic aneurysm is a potentially life-threatening condition: If the body's major blood vessel ruptures, it can prove deadly.

17 Jul 2014

Researchers develop world's first T-cell peptide-based vaccine for heart disease

Researchers at Wayne State University have made a fundamental discovery and, in subsequent collaboration with scientists at La Jolla Institute for Allergy and Immunology (LIAI), are one step closer to the goal of developing the world's first T-cell peptide-based vaccine for heart disease - the number one killer in the nation.

17 Jul 2014

Study finds 20% overall drop per decade in deaths after stroke

Fewer Americans are having strokes and those who do have a lower risk of dying from them finds a new study led by Johns Hopkins Bloomberg School of Public Health researchers.

16 Jul 2014

Rates of stroke incidence, subsequent death decrease among black and white U.S. adults

In a study that included a large sample of black and white U.S. adults from several communities, rates of stroke incidence and subsequent death decreased from 1987 to 2011, with decreases varying across age-groups, according to a study in the July 16 issue of JAMA.

16 Jul 2014

Cordis launches SABER Catheter for treatment of patients with Peripheral Arterial Disease

Cordis Corporation announced today the launch of its SABER PTA Dilatation Catheter ("SABER Catheter") for the treatment of patients with Peripheral Arterial Disease (PAD).

1 Jul 2014

Non-surgical gum disease treatment reduces thickness of wall of arteries

A simple non-surgical gum disease treatment markedly reduces the thickness of the wall of the arteries, a risk factor for heart disease, according to a first of its kind study among Aboriginal Australians.

28 Jun 2014

African American women respond differently to anti-inflammatory effect of aspirin than white women

African American women respond differently to the anti-inflammatory effect of aspirin than do white American women, new research finds.

23 Jun 2014

Study reveals that inflammasomes remain active even after cell death

Even after a cell dies, components of the immune system remain active and continue to fuel inflammatory reactions.

23 Jun 2014

New driver of atherosclerosis may prove to be promising therapeutic target

A new driver of atherosclerosis has been identified by researchers at UT Southwestern Medical Center. This molecule, known as 27HC (27-hydroxycholesterol), has been found to exacerbate the development of the condition, and may prove to be a promising therapeutic target.

20 Jun 2014

La Jolla Institute researchers advance work toward vaccine for heart disease

Research toward the world's first vaccine for heart disease continues to advance at the La Jolla Institute for Allergy and Immunology, with researchers demonstrating significant arterial plaque reduction in concept testing in mice.

18 Jun 2014

Lowering systolic blood pressure below 120 does not appear to provide additional benefit

For decades, common medical wisdom has been "the lower the better" in treating the approximately one in three people in this country who have high blood pressure.

17 Jun 2014

Atherosclerosis News and Research

Further Reading

Findings open up improved treatment possibilities for children suffering from leukaemia

Researchers make significant step forward in understanding mechanisms that cause leukaemia

Scientists identify long-overlooked function of vascular smooth muscle cells in atherosclerosis

Midlife hypertension link to later-life cognitive decline strengthened

Scientists discover gene that plays vital role in blood vessel formation

CardioNova initiates Phase 1b clinical trial with AtheroNova's AHRO-001

Diet rich in soy may help feminine hearts, but timing matters

UTHealth scientists identify inhibitory switch to prevent peripheral vascular disease

Study examines mechanism of bone-protective properties of California dried plums

Surgeon explains who needs screening for abdominal aortic aneurysms

Researchers develop world's first T-cell peptide-based vaccine for heart disease

Study finds 20% overall drop per decade in deaths after stroke

Rates of stroke incidence, subsequent death decrease among black and white U.S. adults

Cordis launches SABER Catheter for treatment of patients with Peripheral Arterial Disease

Non-surgical gum disease treatment reduces thickness of wall of arteries

African American women respond differently to anti-inflammatory effect of aspirin than white women

Study reveals that inflammasomes remain active even after cell death

New driver of atherosclerosis may prove to be promising therapeutic target

La Jolla Institute researchers advance work toward vaccine for heart disease

Lowering systolic blood pressure below 120 does not appear to provide additional benefit

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News